Habitrol
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Ohio State University
Overview
Habitrol is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Habitrol clinical trials
Explore related
Medical disclaimer. This page summarizes research about Habitrol for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.